Nanotherapy for rheumatoid arthritis: A ceria nanoparticle–mesenchymal stem cell nanovesicle hybrid system

Authors

Xinlong He (ORCID: https://orcid.org/0000-0003-2894-8250)
Kai Zhou (ORCID: https://orcid.org/0000-0002-9241-2592)
Jing Zheng (ORCID: https://orcid.org/0000-0003-2790-1143)

Institutions

Sichuan University (CN)
Chengdu University of Information Technology (CN)
West China Hospital of Sichuan University (CN)
State Key Laboratory of Biotherapy

Publication Details

Journal: MedComm – Biomaterials and Applications
Published: 2024-08-11
DOI: https://doi.org/10.1002/mba2.92
Primary Topic: Advanced Drug Delivery Systems
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Nanotherapy for rheumatoid arthritis: A ceria nanoparticle–mesenchymal stem cell nanovesicle hybrid system

Xinlong He, Kai Zhou, Jing Zheng

Aug 11, 2024

MedComm – Biomaterials and Applications

Advanced Drug Delivery Systems

article

Nanotherapy for rheumatoid arthritis: A ceria nanoparticle–mesenchymal stem cell nanovesicle hybrid system

Xinlong He, Kai Zhou, Jing Zheng

August 11, 2024article en

Abstract

No abstract available for this paper.

MedComm – Biomaterials and ApplicationsVol. 3(3)

Sichuan University (CN), Chengdu University of Information Technology (CN), West China Hospital of Sichuan University (CN), State Key Laboratory of Biotherapy

Zero hunger

Openalex Percentile: Top 90%

Advanced Drug Delivery Systems

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.